Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 285 entries
View as:

Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT04373967 Org: User:
Start: 04/29/20 End: 12/02/21 Due: 12/02/22

A Multicenter Randomized Double-blind Clinical Study Evaluated the Safety, Pharmacokinetic and Pharmacodynamic Characteristics of Roflumilast in COPD Patients

Phase: N/A Priority: Normal
NCT ID: NCT02671942 Org: User:
Start: 03/31/16 End: 06/13/18 Due: 06/13/19

A Phase I Study of TQ-B3101 on Tolerance and Pharmacokinetics

Phase: N/A Priority: Normal
NCT ID: NCT03019276 Org: User:
Start: 07/05/17 End: 12/31/18 Due: 12/31/19

A Clinical Study of AL2846 Capsule Combined With Gemzar Injection in the Treatment of Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06278493 Org: User:
Start: 08/23/18 End: 05/01/23 Due: 05/01/24

A Study on Safety and Efficacy of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Patients With Advanced Biliary Adenocarcinoma/Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03825705 Org: User:
Start: 04/23/19 End: 01/01/21 Due: 01/01/22

A Clinical Study to Evaluate the Efficacy of TQA3038 Injection in Patients With Chronic Hepatitis B

Phase: N/A Priority: Normal
NCT ID: NCT06452693 Org: User:
Start: 06/30/24 End: 09/30/26 Due: 09/30/27

Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05830500 Org: User:
Start: 06/19/23 End: 12/31/28 Due: 12/31/29

Study of TQB2450 in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck（R/M SCCHN）

Phase: N/A Priority: Normal
NCT ID: NCT03855384 Org: User:
Start: 06/11/19 End: 05/30/21 Due: 05/30/22

A Clinical Study of TQB3454 Tablets in the Treatment of Advanced Biliary Carcinoma.

Phase: N/A Priority: Normal
NCT ID: NCT05987358 Org: User:
Start: 10/31/23 End: 12/31/26 Due: 12/31/27

A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3303 Tablets

Phase: N/A Priority: Normal
NCT ID: NCT04275050 Org: User:
Start: 04/30/20 End: 04/30/22 Due: 04/30/23

A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3474 Injection

Phase: N/A Priority: Normal
NCT ID: NCT04144855 Org: User:
Start: 11/27/18 End: 05/30/21 Due: 05/30/22

A Trial to Assess the Bioequivalence of Tiotropium Bromide Inhalation Powder in Healthy Adult Participants Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT06487416 Org: User:
Start: 06/10/24 End: 10/31/24 Due: 10/31/25

A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06738979 Org: User:
Start: 03/31/25 End: 08/31/26 Due: 08/31/27

A Study to Evaluate the Sensitivity and Specificity of Inhaled Methacholine in Bronchial Provocation Test

Phase: N/A Priority: Normal
NCT ID: NCT05634473 Org: User:
Start: 12/31/22 End: 06/30/23 Due: 06/30/24

A Study to Evaluate the Efficacy and Safety of Bendamustine Hydrochloride Injection

Phase: N/A Priority: Normal
NCT ID: NCT04569838 Org: User:
Start: 05/31/12 End: 08/31/16 Due: 08/31/17

Gemcitabine and Cisplatin With/Without Anlotinib in Advanced Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03601975 Org: User:
Start: 08/27/18 End: 07/30/21 Due: 07/30/22

A Phase I Study of Subutinib Maleate Capsules on Toleration and Pharmacokinetics

Phase: N/A Priority: Normal
NCT ID: NCT01806376 Org: User:
Start: 03/31/13 End: 09/30/14 Due: 09/30/15

Study of Recombinant Human Coagulation Factor VIIa for Injection (FⅦa) in Patients With Hemophilia.

Phase: N/A Priority: Normal
NCT ID: NCT04768699 Org: User:
Start: 12/01/20 End: 12/01/21 Due: 12/01/22

A Study of AL2846 Versus Zoledronic Acid in Subjects With Advanced Non-Small Cell Lung Cancer With Bone Metastasis

Phase: N/A Priority: Normal
NCT ID: NCT04325776 Org: User:
Start: 09/24/20 End: 11/30/21 Due: 11/30/22

A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3720 Tablets

Phase: N/A Priority: Normal
NCT ID: NCT04853498 Org: User:
Start: 06/19/21 End: 05/30/23 Due: 05/30/24

Study of Methylnaltrexone in Opioid-Induced Constipation Patients

Phase: N/A Priority: Normal
NCT ID: NCT02574819 Org: User:
Start: 04/30/15 End: 04/30/17 Due: 04/30/18

A Clinical Study of TQB2450 Combined With Anlotinib in Limited-Stage Small Cell Lung Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT06469879 Org: User:
Start: 09/30/24 End: 09/30/26 Due: 09/30/27

A Clinical Trial of TQB3909 Tablets Combined With TQB3702 Tablets in Patients With Hematologic Malignancy

Phase: N/A Priority: Normal
NCT ID: NCT06211751 Org: User:
Start: 01/31/24 End: 06/30/26 Due: 06/30/27

A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06860971 Org: User:
Start: 04/18/25 End: 01/31/28 Due: 01/31/29

Study of Anlotinib in Patients With Esophageal Squamous Cell Carcinoma (ALTER1102)

Phase: N/A Priority: Normal
NCT ID: NCT02649361 Org: User:
Start: 01/31/16 End: 07/23/18 Due: 07/23/19